Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00994734 · ClinicalTrials.gov registry record · NA
Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion
A NA study, sponsored by Gynuity Health Projects.
- Completed
- Registry status
- NA
- Development phase
- 615
- Enrollment target
NCT00994734 is a NA study that has completed, run by Gynuity Health Projects. The registered enrollment target is 615 participants.
The verdict
NCT00994734, a NA study, has completed, sponsored by Gynuity Health Projects.
- COMPLETED
- Registry status
- NA
- Development phase
- 615 participants
- Enrollment target
Study Summary
The primary aim of this study is to assess the acceptability of home-use mifepristone for termination of pregnancy among women who choose it and their providers. The investigators' secondary aims are to assess rates of follow-up, adherence, efficacy, complications, lost productivity, and to estimate the minimum proportion of women who choose home-use over clinic use of mifepristone.
Interventions
- DRUG Mifepristone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 615 participants |
| Start Date | 2009-05 |
| Est. Completion | 2011-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00994734
The ClinicalTrials.gov registry entry for NCT00994734 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 615 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gynuity Health Projects, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mifepristone is the first listed.
NCT00994734 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00994734 about?
NCT00994734 is a clinical study titled "Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion". The primary aim of this study is to assess the acceptability of home-use mifepristone for termination of pregnancy among women who choose it and their providers. The investigators' secondary aims are to assess rates of follow-up, adherence, efficacy, complications, lost productivity, and to estimate...
What is the current status of trial NCT00994734?
This trial is currently completed. It is a NA study. The enrollment target is 615 participants. The study started on 2009-05. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00994734?
The interventions under investigation include: Mifepristone (DRUG).
Who is sponsoring clinical trial NCT00994734?
This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.